Genfit SA(NASDAQ:GNFT) 
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, autoimmune, and fibrotic diseases affecting primarily the liver and gastroenterology. The company's lead products include Elafibranor, which is in pivotal Phase III clinical trials for ...
Website: http://www.genfit.com
Founded: 1999
Full Time Employees: 203
CEO: Pascal Prigent
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.36
H 3.36
L 3.34
C 3.36
V 7,856
10EMA 3.36
20EMA 3.36
60EMA 3.36
120EMA 3.36
250EMA 3.36